2019

Asehnoune, K.; Futier, E.; Feuillet, F.; Roquilly, A. PACMAN Trial Protocol, Perioperative Administration of Corticotherapy on Morbidity and Mortality After Non-Cardiac Major Surgery: A Randomised, Multicentre, Double-Blind, Superiority Study. BMJ Open 2019, 9, e021262. https://doi.org/10.1136/bmjopen-2017-021262.

Aubrun, F.; Nouette-Gaulain, K.; Fletcher, D.; Belbachir, A.; Beloeil, H.; Carles, M.; Cuvillon, P.; Dadure, C.; Lebuffe, G.; Marret, E.; Martinez, V.; Olivier, M.; Sabourdin, N.; Zetlaoui, P. Revision of Expert Panel’’s Guidelines on Postoperative Pain Management. Anaesth Crit Care Pain Med 2019. https://doi.org/10.1016/j.accpm.2019.02.011.

Ben Hamou, A.; Espiard, S.; Do Cao, C.; Ladsous, M.; Loyer, C.; Moerman, A.; Boury, S.; Kyheng, M.; Dhaenens, C.; Tiffreau, V.; Pigny, P.; Lebuffe, G.; Caiazzo, R.; Aubert, S.; Vantyghem, M. Systematic Thyroid Screening in Myotonic Dystrophy: Link between Thyroid Volume and Insulin Resistance. Orphanet J Rare Dis 2019, 14, 42. https://doi.org/10.1186/s13023-019-1019-3.

Beuscart, J.; Petit, S.; Gautier, S.; Wierre, P.; Balcaen, T.; Lefebvre, J.; Kambia, N.; Bertoux, E.; Mascaut, D.; Barthélémy, C.; Cuny, D.; Puisieux, F.; Décaudin, B. Polypharmacy in Older Patients: Identifying the Need for Support by a Community Pharmacist. BMC Geriatr 2019, 19, 277. https://doi.org/10.1186/s12877-019-1276-y.

Casasnovas, R.; Bouabdallah, R.; Brice, P.; Lazarovici, J.; Ghesquieres, H.; Stamatoullas, A.; Dupuis, J.; Gac, A.; Gastinne, T.; Joly, B.; Bouabdallah, K.; Nicolas-Virelizier, E.; Feugier, P.; Morschhauser, F.; Delarue, R.; Farhat, H.; Quittet, P.; Berriolo-Riedinger, A.; Tempescul, A.; Edeline, V.; Maisonneuve, H.; Fornecker, L.; Lamy, T.; Delmer, A.; Dartigues, P.; Martin, L.; André, M.; Mounier, N.; Traverse-Glehen, A.; Meignan, M. PET-Adapted Treatment for Newly Diagnosed Advanced Hodgkin Lymphoma (AHL2011): A Randomised, Multicentre, Non-Inferiority, Phase 3 Study. Lancet Oncol. 2019. https://doi.org/10.1016/S1470-2045(18)30784-8.

Charlier, P.; Cabon, M.; Herman, C.; Benouna, F.; Logier, R.; Houfflin-Debarge, V.; Jeanne, M.; De Jonckheere, J. Comparison of Multiple Cardiac Signal Acquisition Technologies for Heart Rate Variability Analysis. J Clin Monit Comput 2019. https://doi.org/10.1007/s10877-019-00382-0.

Chávez-Talavera, O.; Wargny, M.; Pichelin, M.; Descat, A.; Vallez, E.; Kouach, M.; Bigot-Corbel, E.; Joliveau, M.; Goossens, J.; Le May, C.; Hadjadj, S.; Hanf, R.; Tailleux, A.; Staels, B.; Cariou, B. Bile Acids Associate with Glucose Metabolism, but Do Not Predict Conversion from Impaired Fasting Glucose to Diabetes. Metab. Clin. Exp. 2019, 154042. https://doi.org/10.1016/j.metabol.2019.154042.

Chen, A.; Mokrane, F.; Schwartz, L.; Morschhauser, F.; Stamatoullas, A.; Schiano de Colella, J.; Vercellino, L.; Casasnovas, O.; Chauchet, A.; Delmer, A.; Nicolas-Virelizier, E.; Ghesquières, H.; Moles-Moreau, M.; Schmitt, A.; Dulery, R.; Bouabdallah, K.; Borel, C.; Touati, M.; Deau-Fischer, B.; Peyrade, F.; Seban, R.; Manson, G.; Armand, P.; Houot, R.; Dercle, L. F-FDG PET/CT Response Predicts Survival in Relapsed/Refractory Hodgkin Lymphoma Treated with Nivolumab. J. Nucl. Med. 2019. https://doi.org/10.2967/jnumed.119.232827.

Chiu, H.; Trisal, P.; Bjorklund, C.; Carrancio, S.; Toraño, E.; Guarinos, C.; Papazoglou, D.; Hagner, P.; Beldi-Ferchiou, A.; Tarte, K.; Delfau-Larue, M.; Morschhauser, F.; Ramsay, A.; Gandhi, A. Combination Lenalidomide-Rituximab Immunotherapy Activates Anti-Tumour Immunity and Induces Tumour Cell Death by Complementary Mechanisms of Action in Follicular Lymphoma. Br. J. Haematol. 2019. https://doi.org/10.1111/bjh.15797.

Clavier, T.; Ramen, J.; Dureuil, B.; Veber, B.; Hanouz, J.; Dupont, H.; Lebuffe, G.; Besnier, E.; Compere, V. Use of the Smartphone App WhatsApp as an E-Learning Method for Medical Residents: Multicenter Controlled Randomized Trial. JMIR Mhealth Uhealth 2019, 7, e12825. https://doi.org/10.2196/12825.

Cottereau, A.; Nioche, C.; Dirand, A.; Clerc, J.; Morschhauser, F.; Casasnovas, O.; Meignan, M.; Buvat, I. F-FDG-PET Dissemination Features in Diffuse Large B Cell Lymphoma Are Prognostic of Outcome. J. Nucl. Med. 2019. https://doi.org/10.2967/jnumed.119.229450.

Dercle, L.; Mokrane, F.; Schiano de Colella, J.; Stamatoullas, A.; Morschhauser, F.; Brice, P.; Ghesquières, H.; Casasnovas, O.; Chen, A.; Manson, G.; Houot, R. Unconventional Immune-Related Phenomena Observed Using 18F-FDG PET/CT in Hodgkin Lymphoma Treated with Anti PD-1 Monoclonal Antibodies. Eur. J. Nucl. Med. Mol. Imaging 2019. https://doi.org/10.1007/s00259-019-04310-x.

Descat, A.; Lecoeur, M.; Kouach, M.; Goossens, L.; Thelliez, A.; Odou, P.; Decaudin, B.; Goossens, J. Simultaneous Determination of Di(2-Ethylhexyl) Phthalate and Diisononylcyclohexane-1,2-Dicarboxylate and Their Monoester Metabolites in Four Labile Blood Products by Liquid Chromatography Tandem Mass Spectrometry. J Pharm Biomed Anal 2019, 181, 113063. https://doi.org/10.1016/j.jpba.2019.113063.

Devauchelle, P.; Elmerich, J.; Laforest, C.; Lefort, H.; Jeanne, M. [Management of severe burn pain]. Rev Infirm 2019, 68, 23–24. https://doi.org/10.1016/j.revinf.2019.10.006.

Devauchelle, P.; Jeanne, M.; Fréalle, E. Mucormycosis in Burn Patients. J Fungi (Basel) 2019, 5. https://doi.org/10.3390/jof5010025.

Dreyling, M.; Santoro, A.; Mollica, L.; Leppä, S.; Follows, G.; Lenz, G.; Kim, W.; Nagler, A.; Dimou, M.; Demeter, J.; Özcan, M.; Kosinova, M.; Bouabdallah, K.; Morschhauser, F.; Stevens, D.; Trevarthen, D.; Munoz, J.; Rodrigues, L.; Hiemeyer, F.; Miriyala, A.; Garcia-Vargas, J.; Childs, B.; Zinzani, P. Long-Term Safety and Efficacy of the PI3K- Inhibitor Copanlisib in Patients with Relapsed or Refractory Indolent Lymphoma: 2-Year Follow-up of the CHRONOS-1 Study. Am. J. Hematol. 2019. https://doi.org/10.1002/ajh.25711.

Ferrand, É.; Odou, P.; Lebel, D.; Bussières, J. [Evaluation of knowledge and perceptions of pharmacists and residents pharmacists about bibliometric indicators applied to the scientific literature in pharmacy]. Ann Pharm Fr 2019. https://doi.org/10.1016/j.pharma.2018.11.005.

Ghesquieres, H.; Chevrier, M.; Laadhari, M.; Chinot, O.; Choquet, S.; Moluçon-Chabrot, C.; Beauchesne, P.; Gressin, R.; Morschhauser, F.; Schmitt, A.; Gyan, E.; Hoang-Xuan, K.; Nicolas-Virelizier, E.; Cassoux, N.; Touitou, V.; Le Garff-Tavernier, M.; Savignoni, A.; Turbiez, I.; Soumelis, V.; Houillier, C.; Soussain, C. Lenalidomide in Combination with Intravenous Rituximab (REVRI) in Relapsed/Refractory Primary CNS Lymphoma or Primary Intraocular Lymphoma: A Multicenter Prospective \"Proof of Concept\" Phase II Study of the French Oculo-Cerebral Lymphoma (LOC) Network and the Lymphoma Study Association (LYSA). Ann. Oncol. 2019. https://doi.org/10.1093/annonc/mdz032.

Goffard, A.; Odou, P.; Aliouat, E.; Aliouat-Denis, C.; Carnoy, C.; Décaudin, B.; Damien, C.; Hamoudi, M.; Pinçon, C.; Quelennec, K.; Zanetti, S.; Ravaux, P.; Standaert, A. Development and Evaluation of a Hybrid Course in Clinical Virology at a Faculty of Pharmacy in Lille, France. JMIR Med Educ 2019, 5, e10766. https://doi.org/10.2196/10766.

Goossens, J.; Bailly, C. Ursodeoxycholic Acid and Cancer: From Chemoprevention to Chemotherapy. Pharmacol. Ther. 2019, 107396. https://doi.org/10.1016/j.pharmthera.2019.107396.

Hamroun, A.; Nitel Hadj, G.; Bignon, A.; Dharancy, S.; Provôt, F.; Lebuffe, G. MELD May Be More than Just a Prediction Tool for Early Waitlist Mortality. Am. J. Transplant. 2019. https://doi.org/10.1111/ajt.15628.

Jauw, Y.; o’’’’Donoghue, J.; Zijlstra, J.; Hoekstra, O.; Menke-van der Houven van Oordt, C.; Morschhauser, F.; Carrasquillo, J.; Zweegman, S.; Pandit-Taskar, N.; Lammertsma, A.; van Dongen, G.; Boellaard, R.; Weber, W.; Huisman, M. Zr-Immuno-PET: Towards a Non-Invasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies in-Vivo. J. Nucl. Med. 2019. https://doi.org/10.2967/jnumed.118.224568.

Kambia, N.; Séverin, I.; Farce, A.; Moreau, E.; Dahbi, L.; Duval, C.; Dine, T.; Sautou, V.; Chagnon, M. In Vitro and in Silico Hormonal Activity Studies of Di-(2-Ethylhexyl)Terephthalate, a Di-(2-Ethylhexyl)Phthalate Substitute Used in Medical Devices, and Its Metabolites. J Appl Toxicol 2019. https://doi.org/10.1002/jat.3792.

Labreche, K.; Daniau, M.; Sud, A.; Law, P.; Royer-Perron, L.; Holroyd, A.; Broderick, P.; Went, M.; Benazra, M.; Ahle, G.; Soubeyran, P.; Taillandier, L.; Chinot, O.; Casasnovas, O.; Bay, J.; Jardin, F.; Oberic, L.; Fabbro, M.; Damaj, G.; Brion, A.; Mokhtari, K.; Philippe, C.; Sanson, M.; Houillier, C.; Soussain, C.; Hoang-Xuan, K.; Houlston, R.; Alentorn, A.; Moles-Moreau, M.; Gressin, R.; Delwail, V.; Morschhauser, F.; Agape, P.; Jaccard, A.; Ghesquieres, H.; Tempescul, A.; Gyan, E.; Marolleau, J.; Houot, R.; Fornecker, L.; Di Stefano, A.; Detrait, I.; Rahimian, A.; Lathrop, M.; Genet, D.; Davi, F.; Cassoux, N.; Touitou, V.; Choquet, S.; Vital, A.; Polivka, M.; Figarella-Branger, D.; Benouaich-Amiel, A.; Campello, C.; Charlotte, F.; Martin-Duverneuil, N.; Feuvret, L.; Kas, A.; Navarro, S.; Villa, C.; Bielle, F.; Chretien, F.; Tortel, M.; Gauchotte, G.; Uro-Coste, E.; Godfrain, C.; Rigau, V.; Costopoulos, M.; Le Garff-Tavernier, M.; Meyronnet, D.; Rousseau, A.; Adam, C.; Lamy, T.; Chabrot, C.; Boyle, E.; Blonski, M.; Schmitt, A. A Genome-Wide Association Study Identifies Susceptibility Loci for Primary Central Nervous System Lymphoma at 6p25.3 and 3p22.1: A LOC Network Study. Neuro-Oncology 2019, 21, 1039–1048. https://doi.org/10.1093/neuonc/noz088.

Le Rhun, E.; Devos, P.; Bourg, V.; Darlix, A.; Lorgis, V.; Ahle, G.; Boone, M.; Taillandier, L.; Curtit, E.; Gras, L.; Lebrun Frenay, C.; Gramatzki, D.; Ramirez, C.; Simon, N.; Weller, M. Complementary and Alternative Medicine Use in Glioma Patients in France. J. Neurooncol. 2019. https://doi.org/10.1007/s11060-019-03315-8.

Lecoeur, M.; Rabenirina, G.; Schifano, N.; Odou, P.; Ethgen, S.; Lebuffe, G.; Foulon, C. Determination of Acetaminophen and Its Main Metabolites in Urine by Capillary Electrophoresis Hyphenated to Mass Spectrometry. Talanta 2019, 205, 120108. https://doi.org/10.1016/j.talanta.2019.07.003.

Lefebvre, M.; Simon, N.; Vasseur, M.; Sidikou, O.; Barthelemy, C.; Decaudin, B.; Odou, P. Evaluation of Specific Administering Devices for Antineoplastic Drugs Compounded in Syringes in Paediatry: Methodology Proposal. J. Oncol. Pharm. Pract. 2019, 25, 309–316. https://doi.org/10.1177/1078155217733323.

Liberelle, M.; Magnez, R.; Thuru, X.; Bencheikh, Y.; Ravez, S.; Quenon, C.; Drucbert, A.; Foulon, C.; Melnyk, P.; Seuningen, I.; Lebègue, N. MUC4-ErbB2 Oncogenic Complex: Binding Studies Using Microscale Thermophoresis. Sci Rep 2019, 9, 16678. https://doi.org/10.1038/s41598-019-53099-0.

Maiguy-Foinard, A.; Décaudin, B.; Tourneux, P.; Guillois, B.; Blanc, T.; Galène-Gromez, S.; Masse, M.; Odou, P.; Denies, F.; Dervaux, B.; Duhamel, A.; Storme, L. Effect of Multi-Lumen Perfusion Line on Catheter-Related Bacteremia in Premature Infants: Study Protocol for a Cluster-Randomized Crossover Trial. Trials 2019, 20, 115. https://doi.org/10.1186/s13063-019-3218-6.

Montillo, M.; Illés, Á.; Robak, T.; Pristupa, A.; Wach, M.; Egyed, M.; Delgado, J.; Jurczak, W.; Morschhauser, F.; Schuh, A.; Eradat, H.; Shreay, S.; Barrientos, J.; Zelenetz, A. Idelalisib Addition Has Neutral to Beneficial Effects on Quality of Life in Bendamustine/Rituximab-Treated Patients: Results of a Phase 3, Randomized, Controlled Trial. Health Qual Life Outcomes 2019, 17, 173. https://doi.org/10.1186/s12955-019-1232-8.

Morschhauser, F.; Flinn, I.; Advani, R.; Sehn, L.; Diefenbach, C.; Kolibaba, K.; Press, O.; Salles, G.; Tilly, H.; Chen, A.; Assouline, S.; Cheson, B.; Dreyling, M.; Hagenbeek, A.; Zinzani, P.; Jones, S.; Cheng, J.; Lu, D.; Penuel, E.; Hirata, J.; Wenger, M.; Chu, Y.; Sharman, J. Polatuzumab Vedotin or Pinatuzumab Vedotin plus Rituximab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma: Final Results from a Phase 2 Randomised Study (ROMULUS). Lancet Haematol 2019. https://doi.org/10.1016/S2352-3026(19)30026-2.

Morschhauser, F.; Le Gouill, S.; Feugier, P.; Bailly, S.; Nicolas-Virelizier, E.; Bijou, F.; Salles, G.; Tilly, H.; Fruchart, C.; Van Eygen, K.; Snauwaert, S.; Bonnet, C.; Haioun, C.; Thieblemont, C.; Bouabdallah, R.; Wu, K.; Canioni, D.; Meignin, V.; Cartron, G.; Houot, R. Obinutuzumab Combined with Lenalidomide for Relapsed or Refractory Follicular B-Cell Lymphoma (GALEN): A Multicentre, Single-Arm, Phase 2 Study. Lancet Haematol 2019. https://doi.org/10.1016/S2352-3026(19)30089-4.

Morschhauser, F.; Machiels, J.; Salles, G.; Rottey, S.; Rule, S.; Cunningham, D.; Peyrade, F.; Fruchart, C.; Arkenau, H.; Genvresse, I.; Liu, L.; Köchert, K.; Shen, K.; Kneip, C.; Peña, C.; Grevel, J.; Zhang, J.; Cisternas, G.; Reschke, S.; Granvil, C.; Awada, A. On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors. Mol. Cancer Ther. 2019. https://doi.org/10.1158/1535-7163.MCT-19-0466.

Morschhauser, F.; Manier, S.; Fowler, N. Kinase Inhibitors in Large Cell Lymphoma. - 2019. https://doi.org/10.1007/978-3-030-00362-3_15.

Mounier, N.; Anthony, S.; Busson, R.; Thieblemont, C.; Ribrag, V.; Tilly, H.; Haioun, C.; Casasnovas, R.; Morschhauser, F.; Feugier, P.; Delarue, R.; Ysebaert, L.; Sebban, C.; Broussais-Guillaumot, F.; Damaj, G.; Nerich, V.; Jais, J.; Laborde, L.; Salles, G.; Henry-Amar, M. Long-Term Fatigue in Survivors of Non-Hodgkin Lymphoma: The Lymphoma Study Association SIMONAL Cross-Sectional Study. Cancer 2019. https://doi.org/10.1002/cncr.32040.

Nguyen, T.; Fleyfel, M.; Boleslawski, E.; M’’’’Ba, L.; Geniez, M.; Ethgen, S.; Béhal, H.; Lebuffe, G. Effect of Pharmacological Preconditioning with Sevoflurane during Hepatectomy with Intermittent Portal Triad Clamping. HPB (Oxford) 2019. https://doi.org/10.1016/j.hpb.2019.01.009.

Nudel, M.; Baran-Marszak, F.; Bossard, J.; Dubois, R.; Dapvril, H.; Dupuis, J.; Laribi, K.; Bay, J.; Tomowiak, C.; Dreyfus, B.; Lepretre, S.; Demarquette, H.; Wallyn, F.; Wemeau, L.; Wemeau, M.; Poulain, S.; Morschhauser, F.; Cymbalista, F.; Herbaux, C. Characterisation of a New Clinical Presentation of Chronic Lymphocytic Leukaemia: Symptomatic Bronchial Involvement, a Study from the FILO Group. Br. J. Haematol. 2019. https://doi.org/10.1111/bjh.15966.

Pinguet, J.; Kerckhove, N.; Eljezi, T.; Lambert, C.; Moreau, E.; Bernard, L.; Boeuf, B.; Decaudin, B.; Genay, S.; Masse, M.; Storme, L.; Sautou, V.; Richard, D. New SPE-LC-MS/MS Method for the Simultaneous Determination in Urine of 22 Metabolites of DEHP and Alternative Plasticizers from PVC Medical Devices. Talanta 2019, 198, 377–389. https://doi.org/10.1016/j.talanta.2019.01.115.

Przybylski, R.; Bazinet, L.; Firdaous, L.; Kouach, M.; Goossens, J.; Dhulster, P.; Nedjar, N. Harnessing Slaughterhouse By-Products: From Wastes to High-Added Value Natural Food Preservative. Food Chem 2019, 304, 125448. https://doi.org/10.1016/j.foodchem.2019.125448.

Robert, L.; Ficheur, G.; Gautier, S.; Servais, A.; Luyckx, M.; Soula, J.; Decaudin, B.; Glowacki, F.; Puisieux, F.; Chazard, E.; Beuscart, J. Community-Acquired Acute Kidney Injury Induced By Drugs In Older Patients: A Multifactorial Event. Clin Interv Aging 2019, 14, 2105–2113. https://doi.org/10.2147/CIA.S217567.

Roche, M.; Lannoy, D.; Bourdon, F.; Danel, C.; Labalette, P.; Berneron, C.; Simon, N.; Odou, P. Stability of Frozen 1% Voriconazole Eye-Drops in Both Glass and Innovative Containers. Eur J Pharm Sci 2019, 105102. https://doi.org/10.1016/j.ejps.2019.105102.

Roumy, V.; Ruiz Macedo, J.; Bonneau, N.; Samaillie, J.; Azaroual, N.; Encinas, L.; Rivière, C.; Hennebelle, T.; Sahpaz, S.; Antherieu, S.; Pinçon, C.; Neut, C.; Siah, A.; Gutierrez-Choquevilca, A.; Ruiz, L. Plant Therapy in the Peruvian Amazon (Loreto) in Case of Infectious Diseases and Its Antimicrobial Evaluation. J Ethnopharmacol 2019, 112411. https://doi.org/10.1016/j.jep.2019.112411.

Rule, S.; Cartron, G.; Fegan, C.; Morschhauser, F.; Han, L.; Mitra, S.; Salles, G.; Dyer, M. Long-Term Follow-up of Patients with Mantle Cell Lymphoma (MCL) Treated with the Selective Bruton’’s Tyrosine Kinase Inhibitor Tirabrutinib (GS/ONO-4059). Leukemia 2019. https://doi.org/10.1038/s41375-019-0658-7.

Sergeant, N.; Vingtdeux, V.; Eddarkaoui, S.; Gay, M.; Evrard, C.; Le Fur, N.; Laurent, C.; Caillierez, R.; Obriot, H.; Larchanché, P.; Farce, A.; Coevoet, M.; Carato, P.; Kouach, M.; Descat, A.; Dallemagne, P.; Buée-Scherrer, V.; Blum, D.; Hamdane, M.; Buée, L.; Melnyk, P. New Piperazine Multi-Effect Drugs Prevent Neurofibrillary Degeneration and Amyloid Deposition, and Preserve Memory in Animal Models of Alzheimer’’s Disease. Neurobiol. Dis. 2019. https://doi.org/10.1016/j.nbd.2019.03.028.

Simon, N.; Odou, P.; Decaudin, B.; Bonnabry, P.; Fleury-Souverain, S. Chemical Decontamination of Hazardous Drugs: A Comparison of Solution Performances. Ann Work Expo Health 2019. https://doi.org/10.1093/annweh/wxz093.

Simon, N.; Odou, P.; Decaudin, B.; Bonnabry, P.; Fleury-Souverain, S. Efficiency of Degradation or Desorption Methods in Antineoplastic Drug Decontamination: A Critical Review. J Oncol Pharm Pract 2019, 1078155219831427. https://doi.org/10.1177/1078155219831427.

Thieblemont, C.; Howlett, S.; Casasnovas, R.; Mounier, N.; Perrot, A.; Morschhauser, F.; Fruchart, C.; Daguindau, N.; van Eygen, K.; Obéric, L.; Bouabdallah, R.; Pica, G.; Nicolas-Virezelier, E.; Abraham, J.; Fitoussi, O.; Snauwaert, S.; Eisenmann, J.; Lionne-Huyghe, P.; Bron, D.; Tricot, S.; Deeren, D.; Gonzalez, H.; Costello, R.; Le Du, K.; da Silva, M.; Grosicki, S.; Trotman, J.; Catalano, J.; Caballero, D.; Greil, R.; Cohen, A.; Gaulard, P.; Roulin, L.; Takeshita, K.; Casadebaig, M.; Tilly, H.; Coiffier, B. Lenalidomide Maintenance for Diffuse Large B-Cell Lymphoma Patients Responding to R-CHOP: Quality of Life, Dosing, and Safety Results from the Randomised Controlled REMARC Study. Br. J. Haematol. 2019. https://doi.org/10.1111/bjh.16300.

Tilly, H.; Morschhauser, F.; Bartlett, N.; Mehta, A.; Salles, G.; Haioun, C.; Munoz, J.; Chen, A.; Kolibaba, K.; Lu, D.; Yan, M.; Penuel, E.; Hirata, J.; Lee, C.; Sharman, J. Polatuzumab Vedotin in Combination with Immunochemotherapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: An Open-Label, Non-Randomised, Phase 1b-2 Study. Lancet Oncol. 2019. https://doi.org/10.1016/S1470-2045(19)30091-9.

Truant, S.; Baillet, C.; Fulbert, M.; Olivier, A.; Sergent, G.; Turpin, A.; Boleslawski, E.; El Amrani, M.; Huglo, D.; Pruvot, F. Asymmetric Kinetics of Volume and Function of the Remnant Liver after Major Hepatectomy as a Key for Postoperative Outcome - A Case-Matched Study. HPB (Oxford) 2019. https://doi.org/10.1016/j.hpb.2019.10.008.

Van de Wyngaert, Z.; Carpentier, B.; Pascal, L.; Lionne-Huyghe, P.; Leduc, I.; Srour, M.; Vasseur, M.; Demarquette, H.; Terriou, L.; Herbaux, C.; Manier, S.; Bossard, J.; Barbieux, S.; Chauvet, P.; Willaume, A.; Nudel, M.; Bories, C.; Gibier, J.; Facon, T.; Boyle, E. Daratumumab Is Effective in the Relapsed or Refractory Systemic Light-Chain Amyloidosis but Associated with High Infection Burden in a Frail Real-Life Population. Br. J. Haematol. 2019. https://doi.org/10.1111/bjh.16282.

Visade, F.; Lefebvre, A.; Floret, E.; Decaudin, B.; Puisieux, F.; Delecluse, C.; Beuscart, J. Proposition of a Structured List of Information Items to Be Transmitted to Primary Caregivers after In-Hospital Medication Optimization: A Qualitative Study. Acta Clin Belg 2019, 1–6. https://doi.org/10.1080/17843286.2019.1699689.

von Tresckow, B.; Fanale, M.; Ardeshna, K.; Chen, R.; Meissner, J.; Morschhauser, F.; Moskowitz, C.; Zinzani, P.; Giezek, H.; Balakumaran, A.; Vo, T.; Raut, M.; Brice, P. Patient-Reported Outcomes in KEYNOTE-087, a Phase 2 Study of Pembrolizumab in Patients with Classical Hodgkin Lymphoma. Leuk. Lymphoma 2019, 1–7. https://doi.org/10.1080/10428194.2019.1602262.

Wang, M.; Rule, S.; Zinzani, P.; Goy, A.; Casasnovas, O.; Smith, S.; Damaj, G.; Doorduijn, J.; Lamy, T.; Morschhauser, F.; Panizo, C.; Shah, B.; Davies, A.; Eek, R.; Dupuis, J.; Jacobsen, E.; Kater, A.; Le Gouill, S.; Oberic, L.; Robak, T.; Jain, P.; Frigault, M.; Izumi, R.; Nguyen, D.; Patel, P.; Yin, M.; Długosz-Danecka, M. Durable Response with Single-Agent Acalabrutinib in Patients with Relapsed or Refractory Mantle Cell Lymphoma. Leukemia 2019. https://doi.org/10.1038/s41375-019-0575-9.

Zelenetz, A.; Salles, G.; Mason, K.; Casulo, C.; Le Gouill, S.; Sehn, L.; Tilly, H.; Cartron, G.; Chamuleau, M.; Goy, A.; Tam, C.; Lugtenburg, P.; Petrich, A.; Sinha, A.; Samineni, D.; Herter, S.; Ingalla, E.; Szafer-Glusman, E.; Klein, C.; Sampath, D.; Kornacker, M.; Mobasher, M.; Morschhauser, F. Venetoclax plus R- or G-CHOP in Non-Hodgkin Lymphoma: Results from the CAVALLI Phase 1b Trial. Blood 2019. https://doi.org/10.1182/blood-2018-11-880526.